The nucleotide sequence of the phosphoprotein (P) gene of a dolphin morbillivirus (DMV) isolate was determined. Like those of other morbilliviruses the DMV P gene encoded P and C proteins in overlapping open reading frames and V protein by editing the P gene transcript. Among P mRNA based clones the editing site variants GGGC, GGGG, GAGC and GGGGGGC predicting a P protein, and the variants GGGGC and GGGGG predicting a V protein, were found. Surprisingly, the three variants GGGC, GGGG and GAGC were also found among clones generated from genomic RNA of the DMV isolate. Thus, more than one viral genome type appeared to be present in cells infected with the DMV isolate. By a similar analysis of the virus genomes in the tissue from which the DMV isolate was obtained, only the GGGC type was found, indicating that the GGGG and GAGC types arose during adaptation of the virus to growth in cell cultures. No editing site variants likely to have arisen by editing the GAGC type were encountered, and it remains to be determined whether mRNA encoding V protein can be transcribed from genomes with this editing site. Using antisera raised against the common N terminus and unique C termini of the predicted P and V proteins, the in vivo expression of these proteins was demonstrated.
Introduction
The phosphoprotein (P) genes in members of the genus Morbillivirus contain two overlapping long open reading frames (ORFs). One encodes the structural P protein, whereas the other encodes the non-structural C protein.
During transcription of the P gene non-templated G residues can be incorporated in the mRNA at a specific highly conserved editing site. Insertion of one such G residue causes a frameshift in the P ORF, by which it encodes the non-structural V protein. Thus, the first 231 amino acids of the P and V proteins are identical, whereas the remaining residues are different. Throughout the text the common part of the P and V proteins will be referred to as the common N terminus, while the unique parts will be referred to as the P or V protein C termini.
The situation described above has been predicted by nucleic acid sequence analyses for measles virus (MV) (Bellini et al., 1985; Cattaneo et al., 1989) , rinderpest * Author for correspondence. Fax +45 35 28 27 42. The dolphin morbillivirus P gene nucleotide sequence reported in this paper has been submitted to the EMBL/GenBank databases and assigned the accession number Z47758. virus (RPV) (Baron et al., 1993) , canine distemper virus (CDV) (Barrett et al., 1985; Cattaneo et al., 1989) and phocine distemper virus (PDV) (Blixenkrone-Meller et al., 1992; Curran & Rima, 1992) . However, in vivo expression of all three proteins has only been proved for MV (Bellini et al., 1985; Wardrop & Briedis, 1991) . For RPV and CDV, in vivo expression has only been definitively demonstrated for the P protein (Orvell et al., 1985; Sheshberadaran et al., 1986) . For PDV, in vivo expression of both the P and V proteins has been documented (A. Hu & E. Norrby, unpublished results; Rima et al., 1990; Visser et al., 1990) .
In 1990-1992 a hitherto unknown morbillivirus caused a serious epidemic among Mediterranean striped dolphins (Stenella coeruleoalba) (Domingo et al., 1990; Van Bresssem et al., 1993) . We reported previously the N, M and F gene nucleotide sequences of an isolate of this dolphin morbillivirus (DMV) (Blixenkrone-Meller et al., 1994; Bolt et al., 1994) . In this paper we analyse the DMV P gene and its gene products.
Methods
Sequencing strategy. Isolation and adaptation of DMV to Vero cells, total RNA extraction from cell cultures infected with the DMV isolate after it had been plaque purified four times in Vero cells, construction of an mRNA based cDNA library and screening for clones with cDNA inserts of P mRNA have been described previously (Blixenkrone- Moiler et al., 1994; Bolt et al., 1994) . A total of 18 such clones was selected. The insert of one of these clones was sequenced completely. Of the remaining 17 P clones only the editing site regions were sequenced.
A genomic P gene region containing the editing site was PCR amplified from total RNA extracted from Vero cells infected with the DMV isolate and from total RNA extracted from the dolphin lung tissue sample that was also used for obtaining the DMV isolate. Initially, reverse transcription was carried out with primer 1 (Table 1) alone using the First-Strand cDNA synthesis kit according to the recommendations of the manufacturer (Pharmacia). In order to prevent P mRNA from acting as template in the subsequent steps 40 lag RNase A was added to the eDNA synthesis product, which was incubated at 37 °C for 30 min. The reaction was then heated to 95 °C for 5 min, primer 2 (Table 1) and Taq polymerase (AmpliTaq; Perkin Elmer) were added, and amplification was carried out under standard cycling conditions . The PCR products were extracted from agarose gel (GeneClean II kit; Bit 101) and cloned into pGEM-T vector (Promega). The editing sites of 24 such clones with inserts amplified from DMV infected cell culture and ten clones with inserts amplified from dolphin lung tissue were sequenced. As a control for the effect of RNase addition, the editing sites of 17 clones with inserts amplified from DMV infected cell culture without addition of RNase after eDNA synthesis were also sequenced.
All sequencing was carried out by the dideoxynucleotide chaintermination technique (Sanger et al., 1977) using the Sequenase 2.0 kit (USB).
Computer analysis of the nucleotide and deduced amino acid sequences was done as described previously .
In vitro transcription and in vitro translation. Two pSPORT 1 vectors (BRL) with inserts encoding the P/C and V/C proteins, respectively, were linearized with NaeI and transcribed in vitro with T7 RNA polymerase using the Riboprobe Oemini system (Promega). The runoff transcripts were translated in vitro with nuclease treated rabbit reticulocyte lysates (Promega) and [35S]methionine. All reactions were carried out according to the recommendations of the manufacturer.
Production of anlisera against the predicted proteins of the DMV P gene. Fragments of the DMV P gene encoding protein parts were PCR amplified from linearized plasmid DNA using specific primers with restriction sites at their 5' termini. The gene fragments encoding the first 217 amino acid residues of the predicted common DMV P/V protein N terminus, the last 63 amino acids of the V protein C terminus, the last 266 amino acids of the P protein C terminus and the 177 amino acids of the entire C protein were amplified with the primer pairs 3/5, 6/8, 7/8 and 4/5 (Table 1) , respectively. The PCR products were cut with the appropriate restriction enzymes and cloned into the pMAL-c2 vector (New England Biolabs) so that the DMV protein parts were encoded in continuation of the ORF encoding the maltose binding protein of Eseherichia coli. The recombinant fusion proteins were extracted from bacterial lysates using amylose resin as recommended by the manufacturer (New England Biolabs).
Rabbits were immunized subcutaneously with 10-200 lag of purified fusion protein at days 0, 14 and 28. A 1 ml volume ofa 1:1 suspension in Freund's complete adjuvant was used on day 0 and a similar suspension in Freund's incomplete adjuvant was used on days 14 and 28. The rabbits were bled on day 42.
Indirect immunofluorescence assay (IFA), Western blotting and radioimmunoprecipitation assay (RIPA) . The antisera raised against the fusion proteins were used for IFA, Western blotting and RIPA.
IFA was carried out on acetone fixed cytospins of DMV infected Vero cells essentially as described previously (Blixenkrone-Moller, 1989) . Blocking was done with 5 % swine serum. The antisera were used at a 1:15 dilution. Fluorescein conjugated swine anti-rabbit IgG (DAKO) diluted 1 : 25 was used as the secondary antibody.
Western blotting was done as described by Christensen et al. (1993) , except that the RIPA lysis buffer described below was used for harvesting the DMV infected cells.
DMV infected Vero cells were radiolabelled with [35S]methionine as described by A. Hu & E. Norrby (unpublished). The labelled cells were harvested in R1PA lysis buffer (50 mM-Tris ItC1 pH 8.0, 150 mM-NaC1, 1 mM-EDTA, 0.1% SDS, 0.5% sodium deoxycholate, 1% Nonidet P-40, 0.1% gelatin, 1 mM-PMSF and 0-1% aprotinin) and incubated for 1 h on ice before freezing at -20 °C. Before in vivo synthesized proteins were immunoprecipitated, they were denatured by increasing the SDS concentration of 135 gl of cell lysate to 2% and heating the lysate at 70 °C for 30 min. The heated lysate was diluted to 3 ml with lysis buffer and 30 lal of antiserum was added. Immunoprecipitation of in vitro synthesized proteins was performed as described by A. Hn & E. Norrby (unpublished) but with the above lysis buffer without aprotinin. The antigen~ntibody reactions were rotated at 4 °C overnight. Binding of the immune complexes to Protein A-conjugated Sepharose was done as described by A. Hu & E. Norrby (unpublished), except that the above lysis buffer without PMSF and aprotinin was used for all suspension and washing steps. The precipitated proteins were analysed by SDS-PAGE and fluorography.
Results

Nucleotide sequence analyses
The nucleotide sequence of the P gene of the DMV isolate is shown in Fig. 1 . The mRNA based clone did not contain the first 21 nucleotides of the gene. The sequence of this segment and the number of A residues encoded at the end of the gene have been determined previously Bolt et aI., 1994) .
The DMV P gene contains two overlapping long ORFs encoding the P/V and C proteins, respectively. As in other morbilliviruses, the start signals of these two 
rGA~-~+cArc~G~c~Acc~c6rAcATcrrA~Gc~rGca~crAGc'~rAG~AGr~rGrTaGTc~Ar~Ar~ 16 s 5 (Table 2) ; four predicted a P protein and two caused a frameshift predicting a V protein. In order to determine the genomic sequence of the editing site, 24 clones amplified from genomic RNA of the isolate were analysed, and to our surprise three editing site variants were found among these clones (Table 2) . However, none of these variants caused a frameshift. We then examined the editing sites of ten clones amplified from genomic RNA in the dolphin lung tissue sample that was also used for virus isolation. Among these clones only the GGGC editing site, determined for other morbillivirus genomes ( The amplification of cDNA from genomic RNA was based upon the positive sense of the primer used for reverse transcription and the addition of large amounts of RNase before adding a negative sense primer. To check if the added RNase prevented mRNA from being reverse transcribed and amplified, we also cloned PCR products from an identical amplification reaction to which no RNase had been added• Among 16 such clones, we found the three editing site variants that were also found after RNase had been added plus the GGGGG variant. This indicates that the addition of RNase prior to PCR actually prevented amplification of mRNA sequences. In another control experiment an identical amount of RNase was added prior to cDNA synthesis. No DNA could be amplified or cloned from this reaction, which shows that the RNase dosage used was capable of degrading all potential template RNA. Non-specific priming on mRNA appears very unlikely, since the PCR Barrett et al. (1985 Barrett et al. ( , 1993 ; Sidhu et al. (1993) ; 4, Blixenkrone-Moller et al. (1992) . products were gel purified, and only distinct DNA bands of the correct size were used for cloning. Furthermore, only those clones with inserts of the same correct size were sequenced.
Thus, it seems that the sequence of the P gene editing site varied among the DMV genomes present in a cell culture infected with the DMV isolate. The three editing site variants, GGGC, GGGG and GAGC were found to be encoded by DMV genomes. These variants, which all predict a P protein, represented 72 % of the P mRNA based clones examined ( Table 2 ). The mRNA variants GGGGC and GGGGGGC are probably editing products of the GGGC genomic type, whereas the GGGGG mRNA variant appears to have been produced by editing the GGGG genomic type. No variants likely to have arisen from editing of the GAGC genomic type were found. Also, no variants with two or five extra G residues, predicting a truncated P protein, were encountered.
The percentage nucleotide identity of the DMV P gene to those of other morbilliviruses is shown in Table 3 . The results of phylogenetic analyses of the presently available morbillivirus P gene sequences and their predicted proteins (data not shown) were in agreement with previous phylogenetic analyses of DMV Blixenkrone-Moller et al., 1994; Bolt et al., 1994) , showing that DMV is not derived from any known morbillivirus but represents an independent morbillivirus lineage.
Predicted P, V and C proteins of the DMV P gene
The amino acid sequences of the deduced proteins of the DMV P gene are shown in Fig. 1 . These proteins share the characteristics of the predicted P, V and C proteins of other morbilliviruses.
The molecular mass of the deduced P protein is approximately 55 kDa. Among morbilliviruses, the C termini of the P proteins are more conserved than the N termini (Table 3 ). In Sendai virus the former region is believed to bind to both the nucleocapsid and the L protein (Ryan et al., 1991; Smallwood et al., 1994) The molecular mass of the predicted V protein is approximately 35 kDa. The C terminus is well conserved, when compared to other morbilliviruses (Table 3) . The seven cysteine residues of this domain are completely conserved among a considerable number of viruses belonging to the Paramyxoviridae family (Baron et al., 1993) . The arrangement of these cysteine residues exhibits some resemblance to metal binding protein regions (Thomas et al., 1988) , and recently the C terminus of the V protein of MV was reported to bind zinc (Liston & Briedis, 1994) .
The predicted C protein has a molecular mass of approximately 20kDa. The region from residues 102-128 is very well conserved with respect to those of other morbilliviruses, but does not comply completely with the consensus sequence stated by Curran & Rima (1992) .
Demonstration of the P and V proteins in vitro and in vivo
Direct SDS-PAGE analysis of in vitro synthesis reactions showed that proteins of approximately 72 kDa and 51 kDa were produced from mRNA based clones Immunoprecipitation assay of the above translation products using antisera from rabbits immunized against the common N terminus of the predicted DMV P and V proteins (lanes 1), the C terminus of the V protein (lanes 2) or the C terminus of the P protein (lanes 3).
with editing sites predicting P and V proteins, respectively. Proteins the size of the deduced C protein were not detected (Fig. 2a) . RIPA of the in vitro synthesized proteins demonstrated that the 51 kDa protein, as expected for a V protein, was precipitated by the antisera raised against the common N terminus of the predicted DMV P and V proteins and by the antiserum raised against the C terminus of the V protein but not by the antiserum raised against the P protein C terminus (Fig. 2b) .
As expected for a P protein, the 72 kDa protein was precipitated by the antiserum raised against the common P/V N terminus and by the antiserum raised against the P protein C terminus. Surprisingly however, the 72 kDa protein was also precipitated by the antiserum raised against the V protein C terminus (Fig. 2b) . Similar results were obtained by RIPA of in vivo synthesized proteins (Fig. 3a) . However, in Western blotting the antiserum against the V protein C terminus reacted with a protein the size of the V protein, whereas no reactivity with the P protein could be detected (Fig.   3b ).
Besides the putative P protein, the antiserum against the P protein C terminus also precipitated proteins giving bands of various intensities in the range 10-40 kDa from the in vitro translation reaction of the clone predicting a P protein (Fig. 2 b) and in vivo synthesized proteins in the range 30~0 kDa (Fig. 3 a) . In analyses ofparamyxovirus P genes, the in vitro translation system used is known to give rise to products of internal initiation (Thomas et al., 1988) . However, the antiserum against the V protein C terminus did not precipitate any comparable proteins from the in vitro translation reaction of the clone predicting a V protein (Fig. 2b) . Thus, besides the P protein, the proteins precipitated by the antiserum against the P protein C terminus are probably protcolysis products of the P protein. The identity of the bands at approximately 21 kDa in Western blotting (Fig. 3b) is unknown.
The molecular masses of the in vitro and in vivo synthesized DMV P and V proteins assessed by mobility in SDS PAGE are within thc ranges dctcrmined for the same proteins of other morbilliviruses. As observed for other morbilliviruses the estimates of molecular mass based on SDS PAGE varied considerably from the molecular masses of the proteins predicted from the nucleotide sequence data. This is generally attributed to phosphorylation of the proteins, which inhibits binding of SDS, causing them to migrate more slowly in SDS PAGE than non-phosphorylated proteins of the same size (Bellini et al., 1985; Cattaneo et al., 1989; A. Hu & E. Norrby, unpublished results; Lamb & Paterson, 199 l ; Orvell et al., 1985; Wardrop & Briedis, 1991) .
By IFA all three antisera raised against DMV P and V protein regions gave rise to a specific diffuse cytoplasmic fluorescence in DMV infected cells (Fig. 4) .
The antiserum raised against the C protein of DMV failed to react in either Western blotting, RIPA or IFA. Some degradation of the fusion protein used for immunization against the C protein was observed upon SDS-PAGE analysis and Coomassie blue staining of the purified fusion proteins (data not shown). The degradation may be an explanation for the negative results obtained with this antiserum.
Discussion
We sequenced the P gene of a DMV isolate, examined P gene editing site variants among mRNA and genomic RNA, and analysed the expression of the genes encoded by the P gene.
A fragment of the P gene of another DMV isolate, corresponding to nucleotides 411-799 of the present P gene, has been sequenced previously . Nucleotide differences between this and the present sequence are found at positions 412, 596, 597 and 780. All four nucleotide alterations predict amino acid differences.
The reason for the apparent cross-reactivity between the intended V protein specific antiserum and the P protein in immunoprecipitation assay but not in Western blotting is unknown. Stretches of amino acid homology between the C terminus of the predicted V protein and the entire deduced P protein capable of causing crossreactions do not seem to exist. Other conceivable explanations for the reactivity of antiserum against the V protein C terminus with a protein the size of the P protein are ribosomal frameshifting or the existence of an alternative editing site. However, ribosomal frameshifting is believed to require formation of an RNA pseudoknot (Brierley et al., 1989; Craigen & Caskey, 1987) and the DMV P gene appears to contain neither sequences capable of forming this structure nor an alternative editing site.
Despite the inexplicable reactivity of the intended V protein specific antiserum our results show that the P gene of DMV, like those of MV and PDV, directs the synthesis of the two proteins P and V, with common N termini and unique C termini.
In MV and PDV the P mRNA editing site variant GGGGGC with two non-templated G residues has been found. This variant predicts a truncated P/V protein called the I protein (Blixenkrone-Moller et at., 1992; Gombart et al., 1992; A. Hu & E. Norrby, unpublished results) . In the present study, no mRNA based clones predicting a I protein were encountered, and no putative I proteins were detected by immunoprecipitation. Thus it seems that the editing process of DMV is strictly controlled. A similar conclusion can be drawn for RPV (Baron et al., 1993) .
In immunofluorescence assays of MV the P protein was attached to distinct cytoplasmic granules that were known to contain virus nucleocapsids, whereas the V protein seemed to be diffusely dispersed throughout the entire cytoplasm (Bellini et al., 1985; Wardrop & Briedis, 1991) . In the present study all three antisera towards the P and/or V proteins of DMV gave rise to a diffuse fluorescence over the entire cytoplasm. Whether this represents a difference between DMV and MV or is simply due to the fact that we were unable to detect cells at an early stage of infection remains to be determined.
It is surprising that in the present study C protein was not detected after in vitro translation, since C protein was demonstrated using similar translation systems with in vitro or in vivo produced P mRNA of other members of the Paramyxoviridae family (Bellini et al., 1985; Cattaneo et al., 1989; Curran & Kolakofsky, 1988; Galinski et al., 1992) . Furthermore, we were unable to demonstrate in vivo expression of the DMV C protein. However, this does not allow us to conclude that the DMV C protein is not expressed in vivo, especially since the antigen used for obtaining the antiserum against the C protein was not of optimal quality.
Nucleotide sequence analyses demonstrated that the three genomic editing site variants, GGGC, GGGG and GAGC were present in Vero cells infected with the DMV isolate. To our knowledge this is the first report of a morbillivirus isolate with more than one viral genome type. In all previously examined morbillivirus genomes only the GGGC type was found, and among the P mRNAs of these viruses only editing site variants likely to have arisen from insertion of extra G residues to the GGGC sequence were encountered (Baron et al., 1993; Blixenkrone-Moller et al., 1992; Cattaneo et al., 1989) .
The apparent absence of the GGGG and GAGC editing site types among clones generated from DMV genomes in dolphin lung tissue indicates that these types arose during adaptation of the virus to Vero cells. The GGGG type was also amplified from a P gene segment in mRNA sense of another isolate of DMV T. Barrett, personal communication) . Thus, DMV may be more likely to mutate in the editing site during adaptation than other morbilliviruses.
No editing site variants likely to be editing products of the GAGC genomic type were encountered among the mRNA based clones. Whether the absence of such variants is due to examination of an insufficient number of clones, or whether the GAGC type is unable to be edited remains to be determined. If the GAGC type does not induce editing, no V protein can be produced from genomes with this P gene editing site. If so, it would be interesting to examine whether viruses with GAGC type genomes are able to multiply without co-infection with viruses with genomic editing sites that induce editing. Such experiments could be relevant to the study of V protein function.
